Cytochrome P450 Pharmacogenetics in Drug Development: In Vitro Studies and Clinical Consequences

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|3|3|289-309

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.3, Iss.3, 2002-06, pp. : 289-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paradoxical Role of Cytochrome P450 3A in the Bioactivation and Clinical Effects of Levo- -Acetylmethadol: Importance of Clinical Investigations to Validate In Vitro Drug Metabolism Studies

By Kharasch Evan D.   Whittington Dale  

Clinical Pharmacokinetics, Vol. 44, Iss. 7, 2005-01 ,pp. : 731-751

Adis International

Access to resources Recommend Favorite

Prioritization of Clinical Drug Interaction Studies Using In Vitro Cytochrome P450 Data:#x201C;Rank Order#x201D; Approach

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 31-35

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment

By Brockmöller Jürgen   Kirchheiner Julia   Meisel Christian   Roots Ivar  

Pharmacogenomics, Vol. 1, Iss. 2, 2000-05 ,pp. : 125-151

Future Medicine

Access to resources Recommend Favorite

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism: Focus On In Vitro Studies

By Donato M.T.   Castell J.V.  

Clinical Pharmacokinetics, Vol. 42, Iss. 2, 2003-01 ,pp. : 153-178

Adis International

Access to resources Recommend Favorite

The Effect of Ageing on Cytochrome P450 Enzymes: Consequences for Drug Biotransformation in the Elderly

By  

Current Medicinal Chemistry, Vol. 14, Iss. 7, 2007-03 ,pp. : 745-757

Bentham Science Publishers

Access to resources Recommend Favorite